In 2022, FSUE Endopharm expanded its list of competencies by launching the manufacture of medicines for use in veterinary.
Logistical difficulties caused by the current geopolitical situation have led to shortages of a number of veterinary medicines in the 2nd quartal of 2022. The most alarming situation is in the segment of analgesics and anesthetics.
Responding to the professional community needs, FSUE Endopharm obtained a license from Rosselkhoznadzor to manufacture medicines for veterinary use and introduced to the domestic market the first veterinary medicine, Tramvet (INN tramadol hydrochloride), an analgesic agent with a mixed mechanism of action. The medicine is used as an analgesic for moderate to severe pain syndrome (postoperative period, injuries, diagnostic or therapeutic manipulations, including dental, and other non-infectious diseases accompanied by pain syndrome) as part of complex therapy for dogs and cats.
It is important to note that Tramvet is not a narcotic or psychotropic drug, and is used in accordance with the requirements generally accepted for all veterinary medicines for veterinary use that contain potent substances.
FSUE Endopharm plans to expand its veterinary product range. By the end of this year, the Enterprise will launch on the market an injectable product with the INN ketamine for non-inhalation general anesthesia. Ketamine is included in List II of the “List of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation”.
The circulation of narcotic and psychotropic medicines in country is subject to legal requirements. In order to assist veterinary professionals, a special subsection has been developed on the website www.endopharm.ru, which will be filled with useful information. The section already contains explanations on the licensing of narcotic drugs and psychotropic substances, as well as on the Tramvet circulation. Registered users can ask questions and consult specialists of FSUE Endopharm, who have many years of experience in the trafficking of narcotic drugs, psychotropic and potent substances, as well as experts of the specially formed Expert Council on Legal Drug Trafficking, whose activities are ensured by an autonomous non-profit organization established by FSUE Endopharm.
Comment type is not specified in the component properties.